Andreas Schröer

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

Efstratios M. Κolibianakis, A. Schultze-Mosgau, Andreas Schröer et al. · Human Reproduction · 2005 · 324 citations · Full text

Veterinary Medicine, Endocrinology, Gynecology +15

Integrated Organizational Identity: A Definition of Hybrid Organizations and a Research Agenda

Urs Jäger, Andreas Schröer · VOLUNTAS International Journal of Voluntary and Nonprofit Organizations · 2013 · 150 citations

Management, Organization Studies, Organizational Behavior +16

Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study

Georg Griesinger, S. von Otte, Andreas Schröer et al. · Human Reproduction · 2007 · 129 citations · Full text

Medicine, Endocrinology, Gynecology +17

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol

Georg Griesinger, A. Schultze-Mosgau, Konstantinos Dafopoulos et al. · Human Reproduction · 2005 · 104 citations

Medicine, Endocrinology, Gynecology +13

Trio exome sequencing is highly relevant in prenatal diagnostics

Heinz Gabriel, Dirk Korinth, M Ritthaler et al. · Prenatal Diagnosis · 2021 · 61 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17